Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
Product Specifications
CAS Number
935283-04-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
508.42
Molecular Formula
C22H15F3N2O7S
Notes
Research use only, not for human use.
Receptor
Antibacterial
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
31271061 1.0 µg DNA
MYMY1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details orb3170785-01 1 mg
3- (2-carboxy-6-formyl-5-hydroxy-3-methylphenoxy) -2-hydroxy-5-methoxy-4-methylbenzoic acid
Sign In for Pricing
View Details